Aquestive Therapeutics, Inc.·4

May 18, 12:36 PM ET

Cioffi Melina 4

4 · Aquestive Therapeutics, Inc. · Filed May 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Aquestive (AQST) SVP Melina Cioffi Shares Withheld for Taxes

What Happened

  • Melina Cioffi, Senior Vice President, Regulatory Affairs at Aquestive Therapeutics (AQST), had 1,667 shares withheld by the company to satisfy her tax withholding obligation in connection with vested Restricted Stock Units (RSUs). The withholding was reported as a disposal at $4.17 per share, totaling $6,951.
  • This was a tax-withholding disposition (Form 4 code F), not an open‑market sale or a purchase — a routine administrative action when equity awards vest.

Key Details

  • Transaction date: 2026-05-15; filing date (Form 4): 2026-05-18 — appears timely.
  • Withheld shares: 1,667 at $4.17 per share; total value of withheld shares: $6,951.
  • Footnote: F1 — shares were withheld by the issuer to satisfy the Reporting Person’s tax withholding obligation related to previously granted RSUs.
  • Shares owned after transaction: not specified in the provided filing excerpt.

Context

  • Tax-withholding dispositions are common when RSUs vest and do not necessarily indicate insider sentiment about the company’s stock. This is a non-sale administrative action (cashless/tax withholding) rather than an active market transaction.

Insider Transaction Report

Form 4
Period: 2026-05-15
Cioffi Melina
SVP, Regulatory Affairs
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-05-15$4.17/sh1,667$6,951273,200 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.
Signature
/s/ Thomas Zalewski, as Attorney-In-Fact|2026-05-19

Documents

1 file
  • 4
    marketforms-73191.xmlPrimary

    PRIMARY DOCUMENT